{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T05:35:37Z","timestamp":1792733737751,"version":"4.5.0"},"reference-count":64,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2014,2,5]],"date-time":"2014-02-05T00:00:00Z","timestamp":1391558400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0087840","type":"journal-article","created":{"date-parts":[[2014,2,5]],"date-time":"2014-02-05T17:04:37Z","timestamp":1391619877000},"page":"e87840","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":51,"title":["Effects of the \u00df2-Adrenoceptor Agonist, Albuterol, in a Mouse Model of Anti-MuSK Myasthenia Gravis"],"prefix":"10.1371","volume":"9","author":[{"given":"Nazanin","family":"Ghazanfari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Morsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen W.","family":"Reddel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,2,5]]},"reference":[{"key":"ref1","first-page":"2843","article-title":"Myasthenia gravis: past, present, and future. J Clin Invest","volume":"116","author":"BM Conti-Fine","year":"2006"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Autoantibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"W Hoch","year":"2001","journal-title":"Nat Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ana.20061","article-title":"Detection and characterization of MuSK antibodies in seronegative myasthenia gravis","volume":"55","author":"J McConville","year":"2004","journal-title":"Ann Neurol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00415-011-6194-7","article-title":"Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis","volume":"259","author":"A Pevzner","year":"2011","journal-title":"J Neurol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ana.22312","article-title":"Autoantibodies to low-density lipoprotein receptor\u2013related protein 4 in myasthenia gravis","volume":"69","author":"O Higuchi","year":"2011","journal-title":"Ann Neurol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0092-8674(00)81252-0","article-title":"Agrin acts via a MuSK receptor complex","volume":"85","author":"DJ Glass","year":"1996","journal-title":"Cell"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nn2026","article-title":"MuSK controls where motor axons grow and form synapses","volume":"11","author":"N Kim","year":"2008","journal-title":"Nat Neurosci"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.neuron.2008.10.006","article-title":"LRP4 Serves as a Coreceptor of Agrin","volume":"60","author":"B Zhang","year":"2008","journal-title":"Neuron"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"ra7","DOI":"10.1126\/scisignal.2000113","article-title":"Dok-7 activates the muscle receptor kinase MuSK and shapes synapse formation","volume":"2","author":"A Inoue","year":"2009","journal-title":"Science Signaling"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.molcel.2010.06.007","article-title":"The cytoplasmic adaptor protein Dok7 activates the receptor tyrosine kinase MuSK via dimerization","volume":"39","author":"E Bergamin","year":"2010","journal-title":"Molecular Cell"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1242\/dev.038711","article-title":"To build a synapse: signaling pathways in neuromuscular junction assembly","volume":"137","author":"H Wu","year":"2010","journal-title":"Development"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.biocel.2010.10.008","article-title":"Muscle Specific Kinase: Organiser of synaptic membrane domains","volume":"43","author":"N Ghazanfari","year":"2011","journal-title":"Int J Biochem Cell Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.2.5857.42","article-title":"Some discoveries on myasthenia gravis: the background","volume":"2","author":"MB Walker","year":"1973","journal-title":"Br Med J"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1212\/01.wnl.0000167132.35865.31","article-title":"Congenital endplate acetylcholinesterase deficiency responsive to ephedrine","volume":"65","author":"M Bestue-Cardiel","year":"2005","journal-title":"Neurology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/brain\/awm325","article-title":"Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes","volume":"131","author":"V Mihaylova","year":"2008","journal-title":"Brain"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Schara U, Barisic N, Deschauer M, Lindberg C, Straub V, <etal>et al<\/etal>.. (2009) Ephedrine therapy in eight patients with congenital myasthenic syndrome due to DOK7 mutations. Neuromuscul Disord 19 828\u2013832.","DOI":"10.1016\/j.nmd.2009.09.008"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1212\/WNL.0b013e3181dd43bf","article-title":"Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7","volume":"74","author":"D Lashley","year":"2010","journal-title":"Neurology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/mus.22176","article-title":"Beneficial effects of albuterol in congenital endplate acetylcholinesterase deficiency and Dok-7 myasthenia","volume":"44","author":"T Liewluck","year":"2011","journal-title":"Muscle Nerve"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/mus.22153","article-title":"Beneficial effect of albuterol in congenital myasthenic syndrome with epsilon-subunit mutations","volume":"44","author":"M Sadeh","year":"2011","journal-title":"Muscle Nerve"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.pediatrneurol.2012.04.022","article-title":"Neuromuscular junction acetylcholinesterase deficiency responsive to albuterol","volume":"47","author":"SH Chan","year":"2012","journal-title":"Pediatr Neurol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.expneurol.2013.06.012","article-title":"A mouse model of the slow channel myasthenic syndrome: Neuromuscular physiology and effects of ephedrine treatment","volume":"248","author":"RG Webster","year":"2013","journal-title":"Exp Neurol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/mus.22006","article-title":"Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts","volume":"44","author":"JT Guptill","year":"2011","journal-title":"Muscle Nerve"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/WCO.0b013e328346d47d","article-title":"Managing the risks of immunosuppression","volume":"24","author":"DS Riminton","year":"2011","journal-title":"Curr Opin Neurol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1212\/WNL.0b013e3182407982","article-title":"Long-lasting treatment effect of rituximab in MuSK myasthenia","volume":"78","author":"J D\u00edaz-Manera","year":"2012","journal-title":"Neurology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199406233302507","article-title":"Myasthenia gravis","volume":"330","author":"DB Drachman","year":"1994","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1212\/01.WNL.0000098887.24618.A0","article-title":"Treatment of autoimmune myasthenia gravis","volume":"61","author":"DP Richman","year":"2003","journal-title":"Neurology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1468-1331.2010.03019.x","article-title":"Guidelines for treatment of autoimmune neuromuscular transmission disorders","volume":"17","author":"GO Skeie","year":"2010","journal-title":"Eur J Neurol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/brain\/awg223","article-title":"Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis","volume":"126","author":"A Evoli","year":"2003","journal-title":"Brain"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1212\/01.WNL.0000065882.63904.53","article-title":"Clinical aspects of MuSK antibody positive seronegative MG","volume":"60","author":"DB Sanders","year":"2003","journal-title":"Neurology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1212\/01.wnl.0000183145.91579.74","article-title":"Nonresponsiveness to acetylcholinesterase agents in patients with MuSK-antibody-positive MG","volume":"65","author":"Y Hatanaka","year":"2005","journal-title":"Neurology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1113\/jphysiol.2013.251827","article-title":"Pyridostigmine but not 3,4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by Muscle Specific Kinase autoantibody","volume":"591","author":"M Morsch","year":"2013","journal-title":"J Physiol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1172\/JCI21545","article-title":"Induction of myasthenia by immunization against muscle-specific kinase","volume":"116","author":"K Shigemoto","year":"2006","journal-title":"J Clin Invest"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/ana.21371","article-title":"Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction","volume":"63","author":"RN Cole","year":"2008","journal-title":"Ann Neurol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.expneurol.2011.04.018","article-title":"Muscle-selective synaptic disassembly and reorganization in MuSK antibody-positive MG mice","volume":"230","author":"AR Punga","year":"2011","journal-title":"Exp Neurol"},{"key":"ref35","first-page":"453","article-title":"Acute severe animal modelof anti-Muscle-specific kinase myasthenia. Arch Neurol","volume":"69","author":"DP Richman","year":"2011"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/brain\/aws025","article-title":"Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice","volume":"135","author":"R Klooster","year":"2012","journal-title":"Brain"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.expneurol.2012.01.025","article-title":"Passive and active immunization models of MuSK-Ab positive myasthenia: Electrophysiological evidence for pre and postsynaptic defects","volume":"234","author":"S Viegas","year":"2012","journal-title":"Exp Neurol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.expneurol.2012.06.034","article-title":"Muscle Specific Kinase autoantibodies cause synaptic failure through progressive wastage of postsynaptic acetylcholine receptors","volume":"237","author":"M Morsch","year":"2012","journal-title":"Exp Neurol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1468-1331.2007.01870.x","article-title":"Clinical and experimental features of MuSK antibody positive MG in Japan","volume":"14","author":"K Ohta","year":"2007","journal-title":"Eur J Neurol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.ajpath.2011.10.031","article-title":"Antibodies against Muscle-Specific Kinase impair both presynaptic and postsynaptic functions in a murine model of myasthenia gravis","volume":"180","author":"S Mori","year":"2012","journal-title":"Am J Path"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1113\/jphysiol.2010.190298","article-title":"Patient autoantibodies deplete postsynaptic Muscle Specific Kinase leading to disassembly of the ACh receptor scaffold and myasthenia gravis in mice","volume":"588","author":"RN Cole","year":"2010","journal-title":"J Physiol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2011.12.005","article-title":"Divalent and monovalent autoantibodies cause dysfunction of MuSK by distinct mechanisms in a rabbit model of myasthenia gravis","volume":"244","author":"S Mori","year":"2012","journal-title":"J Neuroimmunol"},{"key":"ref43","first-page":"e80695","article-title":"MuSK Myasthenia Gravis IgG4 Disrupts the Interaction of LRP4 with MuSK but Both IgG4 and IgG1\u20133 Can Disperse Preformed Agrin-Independent AChR Clusters. PLOS ONE","volume":"11","author":"I Koneczny","year":"2013"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"20783","DOI":"10.1073\/pnas.1313944110","article-title":"MuSK IgG4 auto-antibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4","volume":"110","author":"MG Huijbers","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref45","unstructured":"Westfall TC, Westfall DP (2006) Adrenergic agonists and antagonists. In: Brunton, L. L., Lazo, J. S., Parker, K. L. (eds). <italic>Goodman and Gilman\u2019s the Pharmacological Basis of Therapeutics<\/italic> McGraw-Hill Inc."},{"key":"ref46","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1126\/science.1179220","article-title":"Myasthenia gravis: passive transfer from man to mouse","volume":"190","author":"KV Toyka","year":"1975","journal-title":"Science"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.4049\/jimmunol.169.11.6570","article-title":"Split tolerance in a novel transgenic model of autoimmune myasthenia gravis","volume":"169","author":"S Stacy","year":"2002","journal-title":"J Immunol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1113\/jphysiol.1997.sp022007","article-title":"The contribution of postsynaptic folds to the safety factor for neuromuscular transmission in rat fast- and slow-twitch muscles","volume":"500","author":"SJ Wood","year":"1997","journal-title":"J Physiol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1113\/jphysiol.1979.sp013003","article-title":"The relationship between end-plate size and transmitter release in normal and dystrophic muscles of the mouse","volume":"296","author":"JB Harris","year":"1979","journal-title":"J Physiol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1113\/jphysiol.1992.sp019429","article-title":"Adaptation of quantal content to decreased postsynapitc sensitivity at single endplates in \u03b1-bungarotoxin-treated rats","volume":"458","author":"JJ Plomp","year":"1992","journal-title":"J Physiol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1083\/jcb.200307164","article-title":"MuSK is required for anchoring acetylcholinesterase at the neuromuscular junction","volume":"165","author":"A Cartaud","year":"2004","journal-title":"J Cell Biol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1242\/jcs.092361","article-title":"Rapsyn mediates subsynaptic anchoring of PKA type I and stabilisation of acetylcholine receptor <italic>in vivo<\/italic>","volume":"125","author":"KR Choi","year":"2012","journal-title":"J Cell Sci"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1073\/pnas.0914087107","article-title":"Myosin Va cooperates with PKA RI\u03b1 to mediate maintenance of the endplate <italic>in vivo<\/italic>","volume":"107","author":"IV Roder","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref54","first-page":"107","article-title":"Myasthenia gravis induced in mice by immunization with the recombinant extracellular domain of rat muscle-specific kinase (MuSK) J Neuroimmunol","volume":"175","author":"S Jha","year":"2006"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.2353\/ajpath.2009.090040","article-title":"The effect of plasma from muscle-specific tyrosine kinase myasthenia gravis patients on regenerating endplates","volume":"175","author":"PW ter Beek","year":"2009","journal-title":"Am J Path"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.nmd.2012.11.004","article-title":"Salbutamol benefits children with congenital myasthenic syndrome due to DOK7 mutations","volume":"23","author":"G Burke","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1152\/japplphysiol.00275.2002","article-title":"Selected Contribution: Long-term effects of \u03b22-adrenergic receptor stimulation on alveolar fluid clearance in mice","volume":"93","author":"C Sartori","year":"2002","journal-title":"J Appl Physiol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0091-3057(84)90210-7","article-title":"Stimulation of beta-adrenergic receptors and spontaneous motor activity in mice","volume":"21","author":"PL Goldschmidt","year":"1984","journal-title":"Pharmacol Biochem & Behav"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF02245705","article-title":"Differential sensitivity to the effects of albuterol on locomotor activity and operant behavior","volume":"113","author":"JM O'Donnell","year":"1993","journal-title":"Psychopharmacology"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/j.1476-5381.1993.tb13932.x","article-title":"The effects of \u03b2-adrenoceptor activation on contraction in isolated fast- and slow-twitch skeletal muscle fibres of the rat","volume":"110","author":"SP Cairns","year":"1993","journal-title":"Br J Pharmacol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.1113\/jphysiol.2012.237925","article-title":"Stress-induced increase in skeletal muscle force requires protein kinase A phosphorylation of the ryanodine receptor","volume":"590","author":"DC Andersson","year":"2012","journal-title":"J Physiol"},{"key":"ref62","first-page":"6381","article-title":"Stress-induced increase in muscle force: truth or myth?","volume":"590","author":"S Roatta","year":"2013","journal-title":"J Physiol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"4811","DOI":"10.1113\/jphysiol.2010.196725","article-title":"Cellular mechanisms underlying temporal changes in skeletal muscle protein synthesis and breakdown during chronic \u03b2-adrenoceptor stimulation in mice","volume":"588","author":"R Koopman","year":"2010","journal-title":"J Physiol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/j.biocel.2013.06.025","article-title":"\u03b22-Adrenergic agonists and the treatment of skeletal muscle wasting disorders","volume":"45","author":"OR Joassard","year":"2013","journal-title":"Int J Biochem Cell Biol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0087840","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T08:20:18Z","timestamp":1540282818000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0087840"}},"subtitle":[],"editor":[{"given":"Lin","family":"Mei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,2,5]]},"references-count":64,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0087840","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,5]]}}}